It has been shown that increased estrogen and progesterone levels are related to an increased BPE [25, 26], but also to increased breast cancer risk [27–32], especially for hormone receptor positive cancers [33], consequently relating high BPE to hormone receptor positive cancers. This evidence concerns the gene NR4A1 and breast carcinoma.